Early-stage depletion of regulatory CD4+ T cells in AD mouse models has been shown to worsen cognitive deficits [47], while enhancing their numbers with treatments like IL-2 can improve cognitive function and reduce Aβ plaque load [48]. This evidence concerns the gene CD4 and Cognitive impairment.